BDBM331843 8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxymethyl-2-methoxyphenyl)-1,3,3-trimethyl-3,4-dihydro-1H-quinoxalin-2-one::US10189796, Control compound B::US10435379, Compound Control B

SMILES COc1ccc(CO)cc1-c1ccc2NC(C)(C)C(=O)N(C)c2c1COc1cc(F)ccc1C

InChI Key InChIKey=UDTADUDTSUMNOB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 331843   

TargetInterleukin-6(Homo sapiens (Human))
Santen Pharmaceutical

US Patent
LigandPNGBDBM331843(8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxymet...)
Affinity DataIC50:  123nMAssay Description:1) The subcultured HCE-T was recovered and the cells were seeded at 2.0×104 cells/0.1 mL/well in a 96-well flat bottom culture plate.2) After culturi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-6(Homo sapiens (Human))
Santen Pharmaceutical

US Patent
LigandPNGBDBM331843(8-(5-fluoro-2-methylphenoxymethyl)-7-(5-hydroxymet...)
Affinity DataIC50:  123nMAssay Description:o evaluate the action of the present compounds as a GR agonist, IL-6 production inhibitory action in human corneal epithelial cell line after LPS sti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent